BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14639530)

  • 1. Ebola hemorrhagic fever and septic shock.
    Bray M; Mahanty S
    J Infect Dis; 2003 Dec; 188(11):1613-7. PubMed ID: 14639530
    [No Abstract]   [Full Text] [Related]  

  • 2. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever.
    Bray M; Geisbert TW
    Int J Biochem Cell Biol; 2005 Aug; 37(8):1560-6. PubMed ID: 15896665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-specific anti-viral approach towards Ebola virus infection: a comment on "Against Ebola: type I interferon guard risk and mesenchymal stromal cell combat sepsis".
    Joob B; Wiwanitkit V
    J Zhejiang Univ Sci B; 2015 Mar; 16(3):251-2. PubMed ID: 25743126
    [No Abstract]   [Full Text] [Related]  

  • 4. Against Ebola: type I interferon guard risk and mesenchymal stromal cell combat sepsis.
    Zhang L; Wang H; Zhang YQ
    J Zhejiang Univ Sci B; 2015 Jan; 16(1):1-9. PubMed ID: 25559950
    [No Abstract]   [Full Text] [Related]  

  • 5. Trigger events: enviroclimatic coupling of Ebola hemorrhagic fever outbreaks.
    Pinzon JE; Wilson JM; Tucker CJ; Arthur R; Jahrling PB; Formenty P
    Am J Trop Med Hyg; 2004 Nov; 71(5):664-74. PubMed ID: 15569802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging infections--Ebola and other filoviruses.
    Peters CJ
    West J Med; 1996 Jan; 164(1):36-8. PubMed ID: 8779200
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental study of Ebola hemorrhagic fever in baboon models].
    Luchko SV; Dadaeva AA; Ustinova EN; Sizikova LP; Riabchikova EI; Sandakhchiev LS
    Biull Eksp Biol Med; 1995 Sep; 120(9):302-4. PubMed ID: 8593345
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event.
    Geisbert TW; Young HA; Jahrling PB; Davis KJ; Kagan E; Hensley LE
    J Infect Dis; 2003 Dec; 188(11):1618-29. PubMed ID: 14639531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
    Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
    J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a vaccine against Ebola virus.
    Geisbert TW; Jahrling PB
    Expert Rev Vaccines; 2003 Dec; 2(6):777-89. PubMed ID: 14711361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for Ebola virus infection in Côte d'Ivoire.
    Kunii O; Formenty P; Diarra-Nama J; Nahounou N
    Emerg Infect Dis; 1999; 5(2):312-3. PubMed ID: 10221898
    [No Abstract]   [Full Text] [Related]  

  • 12. Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates.
    Jahrling PB; Geisbert JB; Swearengen JR; Larsen T; Geisbert TW
    J Infect Dis; 2007 Nov; 196 Suppl 2():S400-3. PubMed ID: 17940976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages, monokines, and the metabolic pathophysiology of septic shock.
    Sacco-Gibson NA; Filkins JP
    Prog Clin Biol Res; 1989; 286():203-18. PubMed ID: 2648411
    [No Abstract]   [Full Text] [Related]  

  • 14. Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.
    Geisbert TW; Hensley LE
    Expert Rev Mol Med; 2004 Sep; 6(20):1-24. PubMed ID: 15383160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte apoptosis, caspase activation and inflammatory response in septic shock.
    Delogu G; Famularo G; Tellan G; Marandola M; Antonucci A; Signore M; Marcellini S; Moretti S
    Infection; 2008 Oct; 36(5):485-7. PubMed ID: 18791840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Septic shock--the unravelling of molecular mechanisms.
    Camussi G; Montrucchio G; Dominioni L; Dionigi R
    Nephrol Dial Transplant; 1995 Oct; 10(10):1808-13. PubMed ID: 8592586
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo.
    Formenty P; Leroy EM; Epelboin A; Libama F; Lenzi M; Sudeck H; Yaba P; Allarangar Y; Boumandouki P; Nkounkou VB; Drosten C; Grolla A; Feldmann H; Roth C
    Clin Infect Dis; 2006 Jun; 42(11):1521-6. PubMed ID: 16652308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine and chemokine expression in humans infected with Sudan Ebola virus.
    Hutchinson KL; Rollin PE
    J Infect Dis; 2007 Nov; 196 Suppl 2():S357-63. PubMed ID: 17940971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever.
    Jones SM; Stroher U; Fernando L; Qiu X; Alimonti J; Melito P; Bray M; Klenk HD; Feldmann H
    J Infect Dis; 2007 Nov; 196 Suppl 2():S404-12. PubMed ID: 17940977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fruit bats as reservoirs of Ebola virus.
    Leroy EM; Kumulungui B; Pourrut X; Rouquet P; Hassanin A; Yaba P; Délicat A; Paweska JT; Gonzalez JP; Swanepoel R
    Nature; 2005 Dec; 438(7068):575-6. PubMed ID: 16319873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.